Search - tctmd.com

Displaying 21 - 40 of 115

Sort: Relevancy | Date

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

Presentation TCT 2017

NuPulse: Implantable Counterpulsation for Advanced CHF

Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama, Valluvan Jeevanandam

November 01, 2017

Presentation TCT 2017

Tricuspid Valve Repair and Replacement for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Maurice E. Sarano

October 31, 2017

Presentation TCT 2017

Aortic Valve Replacement for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Howard C. Herrmann

October 31, 2017

Presentation TCT 2017

Mitral Valve Repair and Replacement for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Michael J. Mack

October 31, 2017

Presentation TCT 2017

State-of-the-Art Overview: Device-Based Therapies for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld

October 31, 2017

Presentation TCT 2017

Coronary Revascularization for CHF: Implications From STICH for Complete Revascularization

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Eric Jose Velazquez

October 31, 2017

Presentation SIF 2017

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

Presenter: Michael J. Rinaldi

March 10, 2017

Presentation TCT 2016

NuPulse: Implantable Counterpulsation for Advanced CHF

Presenter: David E. Kandzari, Navin K. Kapur, Valluvan Jeevanandam

November 01, 2016

Presentation TCT 2016

Featured Lecture: Device Overviews and the Promises and Pitfalls of Home Monitoring of CHF

Presenter: JoAnn Lindenfeld, Ileana L. Pina, William T. Abraham

November 01, 2016

Presentation TCT 2016

First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF

Presenter: Emerson C. Perin, Valluvan Jeevanandam

November 01, 2016

Presentation TCT 2016

Electrical Therapies for CHF

Presenter: James E. Udelson, Peter Carson

October 31, 2016

Presentation TCT 2016

State-of-the-Art: Surgical and Device-based LV Remodeling as a Treatment for CHF

Presenter: James E. Udelson, Ileana L. Pina

October 31, 2016

News Daily News

Medication Compliance May Impact Revascularization Outcomes

L.A. McKeown

October 25, 2016

News Opinion Fellow Talk

Top 10 Tricks on Financial Planning for Fellows

Yael L. Maxwell

August 09, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

News Industry News

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

January 03, 2016

News Industry News

World's First Endovascular Neuromodulation Device Implanted in Man for the Treatment of Congestive Heart Failure

November 04, 2015

Presentation TCT 2015

Cell Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Timothy D. Henry

October 14, 2015

Presentation TCT 2015

Gene Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Gary L. Schaer

October 14, 2015

Advertisement

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

NuPulse: Implantable Counterpulsation for Advanced CHF

Tricuspid Valve Repair and Replacement for CHF

Aortic Valve Replacement for CHF

Mitral Valve Repair and Replacement for CHF

State-of-the-Art Overview: Device-Based Therapies for CHF

Coronary Revascularization for CHF: Implications From STICH for Complete Revascularization

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

NuPulse: Implantable Counterpulsation for Advanced CHF

Featured Lecture: Device Overviews and the Promises and Pitfalls of Home Monitoring of CHF

First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF

Electrical Therapies for CHF

State-of-the-Art: Surgical and Device-based LV Remodeling as a Treatment for CHF

Medication Compliance May Impact Revascularization Outcomes

Top 10 Tricks on Financial Planning for Fellows

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

World's First Endovascular Neuromodulation Device Implanted in Man for the Treatment of Congestive Heart Failure

Cell Therapy for CHF

Gene Therapy for CHF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content